Skip to content
value.today

Senesco Technologies Inc.

Formerly Nava Leisure USA, Inc.

Total raised
$12 M
1 round on record
Latest round
$12 M
Mar 2010
First round on record
Mar 2010
Today
Went public
See the company page

Senesco Technologies Inc. is listed today as Eloxx Pharmaceuticals, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Senesco Technologies Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2015$3 MPrivate placement after listing$2 to $10 million

Senesco Technologies Inc.: Private sale, May 2015

Investors in this round

14 investors had bought by the notice of May 15, 2015: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Senesco Technologies Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $10 M offered; $7 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$190,525
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Rector · Executive Officer, Director
  • James A. Graziano · Executive Officer
  • Joel Brooks · Executive Officer
  • Miguel A. de los Rios · Executive Officer
  • Vaughn Smider · Executive Officer, Director
  • Harlan W. Waksal · Director
  • John W. Braca · Director
  • Phillip W. Frost · Director
  • Steven W. Rubin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Axiom Capital Management, Inc. (CRD 26580) · New York, New YorkSold in IN, TX
  • Laidlaw & Company (UK), Ltd. (CRD 119037) · London, United KingdomSold in NY
  • Newport Coast Securities, Inc. (CRD 16944) · New York, New YorkSold in FL, IL, OH, VA
  • Palladium Capital Advisors, LLC (CRD 129400) · New York, New YorkSold in no state named, and outside the US

Remarks in the notice

  • On fees: “Placement agents also received warrants to purchase common stock.”

Signed by David Rector, Chief Executive Officer. Source: SEC Form D, newest notice filed May 15, 2015. Read the notice at the SEC.

equity, optionsSEC
Mar 2010$12 MNo. 1$10 to $50 million

Senesco Technologies Inc.: Raise no. 1, Mar 2010

Investors in this round

51 investors had bought by the notice of Apr 9, 2010: 51 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Senesco Technologies Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$12 M of $12 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$416,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jack Van Hulst · Director, Executive Officer
  • Joel P. Brooks · Executive Officer
  • John E. Thompson · Director, Executive Officer
  • Richard J. Dondero · Executive Officer
  • Christopher N. Forbes · Director
  • David C. Rector · Director
  • Harlan W. Waksal · Director
  • John N. Braca · Director
  • Rudolf C. Stalder · Director
  • Thomas C. Quick · Director
  • Warren J. Isabelle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Ladenburg Thalamnn & Co. (CRD 505) · New York, NySold in no state named

Signed by Joel P. Brooks, Chief Financial Officer and Treasurer. Source: SEC Form D, newest notice filed Apr 9, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Senesco Technologies Inc. chose not to state its revenue in its newest notice of a funding round (May 2015).

    SEC Form D · May 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2015

That is all the official record says: Senesco Technologies Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Senesco Technologies Inc. are on record.

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in Senesco Technologies Inc.
InvestorKindAmountRoundRoleSource
Paul Edward KlaverPersonnot statednot statedHeld preferred stock, 10% owner (Form 3, 2012)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 51 investors.

Largest shareholders today

Institutions holding Eloxx Pharmaceuticals, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Senesco Technologies Inc.
NameRoleNamed in
David RectorExecutive officerMay 2015
James A. GrazianoExecutive officerMay 2015
Joel BrooksExecutive officerMay 2015
Miguel A. de los RiosExecutive officerMay 2015
Vaughn SmiderExecutive officerMay 2015
Jack Van HulstExecutive officerApr 2010
Joel P. BrooksExecutive officerApr 2010
John E. ThompsonExecutive officerApr 2010
Richard J. DonderoExecutive officerApr 2010
David RectorDirectorMay 2015
Harlan W. WaksalDirectorMay 2015
John W. BracaDirectorMay 2015
Phillip W. FrostDirectorMay 2015
Steven W. RubinDirectorMay 2015
Vaughn SmiderDirectorMay 2015
Christopher N. ForbesDirectorApr 2010
David C. RectorDirectorApr 2010
Jack Van HulstDirectorApr 2010
John E. ThompsonDirectorApr 2010
John N. BracaDirectorApr 2010
Rudolf C. StalderDirectorApr 2010
Thomas C. QuickDirectorApr 2010
Warren J. IsabelleDirectorApr 2010

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.